Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × INDUSTRY × chiauranib × Clear all

Phase

Phase 1/2 4 Phase 2 3 Phase 1 3 Phase 3 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Mammography 12 Standard of Care 8 Radiofrequency Ablation 8 Colonoscopy 7 Blood Specimen Collection 7 Uterine Myomectomy 6 Robotic Surgical Procedures 6 Drug Delivery Systems 6 Colposcopy 6 Biopsy 6 Proton Therapy 5 Inositol 5 Cryosurgery 5 Therapeutics 4 Leukapheresis 4 Food 4 Drug Therapy 4 CF regimen 4 Brachytherapy 4 pegylated granulocyte colony-stimulating factor 3 epigallocatechin gallate 3 Uterine Artery Embolization 3 Surgical Procedures, Operative 3 Sunitinib 3 Radiotherapy 3 Paclitaxel 3 Oxaliplatin 3 Human Papillomavirus DNA Tests 3 Folic Acid 3 Dietary Supplements 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05371899 2024-07-15

Mass Balance Study of [14C]Chiauranib

Chipscreen Biosciences, Ltd.

Phase NA Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡